Stereotactic Ablative Radiation Therapy

RADIATION4 trials

Sponsors

University of Texas Southwestern Medical Center, National Cancer Institute, Egypt, National Medical Research Radiological Centre of the Ministry of Health of Russia

Conditions

Breast CancerMetastatic Breast CancerMetastatic CancerOligometastatic DiseaseRenal CancersRenal Cell Carcinoma

Phase 1

Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC

Active, not recruitingNCT02473536

University of Texas Southwestern Medical CenterRenal Cell Carcinoma

Start: 2015-06-01End: 2027-01-01Updated: 2026-01-16

Phase 2

Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer

Active, not recruitingNCT02141919

University of Texas Southwestern Medical CenterRenal Cancers

Start: 2013-06-30End: 2026-06-30Updated: 2025-12-26

Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care

RecruitingNCT06556550

National Medical Research Radiological Centre of the Ministry of Health of RussiaOligometastatic Disease

Start: 2024-05-31End: 2029-12-31Target: 100Updated: 2024-08-16

Unknown Phase

Metastases Directed Therapy for Oligometastatic Breast Cancer

RecruitingNCT06144346

National Cancer Institute, EgyptBreast Cancer, Metastatic Breast Cancer, Metastatic Cancer

Start: 2023-09-20End: 2028-09-20Target: 150Updated: 2023-11-22

Related Papers

Preoperative stereotactic body radiotherapy combined with surgical treatment for renal cell carcinoma and inferior vena cava tumour thrombus: study protocol for a single-arm cohort trial

BMJ Open2022-01-019 citations